• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

On guidelines for comparative effectiveness research using nonrandomized studies in secondary data sources.

作者信息

Schneeweiss Sebastian

出版信息

Value Health. 2009 Nov-Dec;12(8):1041. doi: 10.1111/j.1524-4733.2009.00607.x. Epub 2009 Sep 10.

DOI:10.1111/j.1524-4733.2009.00607.x
PMID:19744290
Abstract
摘要

相似文献

1
On guidelines for comparative effectiveness research using nonrandomized studies in secondary data sources.关于利用二次数据源中的非随机研究进行比较效果研究的指南。
Value Health. 2009 Nov-Dec;12(8):1041. doi: 10.1111/j.1524-4733.2009.00607.x. Epub 2009 Sep 10.
2
Comparative effectiveness research: guidelines for good practices are just the beginning.比较效果研究：良好实践指南仅仅是个开始。
Expert Rev Pharmacoecon Outcomes Res. 2011 Feb;11(1):51-7. doi: 10.1586/erp.10.93.
3
Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I.比较有效性研究的良好研究实践：使用二次数据源定义、报告和解释治疗效果的非随机研究：ISPOR 回顾性数据库分析良好研究实践工作组报告--第一部分。
Value Health. 2009 Nov-Dec;12(8):1044-52. doi: 10.1111/j.1524-4733.2009.00600.x. Epub 2009 Sep 29.
4
Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.比较疗效研究的良好研究实践：利用二次数据源设计非随机治疗效果研究中减轻偏倚和混杂的方法：国际药物经济学和结果研究学会回顾性数据库分析良好研究实践工作组报告--第二部分。
Value Health. 2009 Nov-Dec;12(8):1053-61. doi: 10.1111/j.1524-4733.2009.00601.x. Epub 2009 Sep 10.
5
Revisiting issues, drawbacks and opportunities with observational studies in comparative effectiveness research.重新审视比较有效性研究中观察性研究的问题、局限性和机遇。
J Eval Clin Pract. 2013 Aug;19(4):579-83. doi: 10.1111/j.1365-2753.2011.01802.x. Epub 2011 Nov 29.
6
It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.需要注意的是，真实世界数据（RWD）永远无法取代更为传统且更为可靠的随机对照试验（RCT）数据；然而，新出现的趋势是纳入更具普遍性的数据。引言。
J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl A):S03-4.
7
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.ISPOR 成本效益研究质量改进良好实践工作组报告。
Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.
8
On the limitations of comparative effectiveness research.论比较效果研究的局限性。
Stat Med. 2010 Aug 30;29(19):1991-5; discussion 1996-7. doi: 10.1002/sim.3960.
9
Evaluation of comparative effectiveness research: a practical tool.比较效果研究的评估：一种实用工具。
J Comp Eff Res. 2018 May;7(5):503-515. doi: 10.2217/cer-2018-0007. Epub 2018 Feb 21.
10
Comparative Effectiveness Research and the Surveillance, Epidemiology, and End Results database: what is Comparative Effectiveness Research (CER) and why is it important?比较效果研究与监测、流行病学和最终结果数据库：什么是比较效果研究（CER）以及它为何重要？
Curr Probl Cancer. 2012 Jul-Aug;36(4):208-15. doi: 10.1016/j.currproblcancer.2012.03.010. Epub 2012 Apr 4.

引用本文的文献

1
Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic.基于倾向评分匹配树扫描统计的药物不良事件数据挖掘。
Epidemiology. 2018 Nov;29(6):895-903. doi: 10.1097/EDE.0000000000000907.
2
Clinical Comparative Effectiveness Research Through the Lens of Healthcare Decisionmakers.从医疗保健决策者视角看临床比较效果研究
Ochsner J. 2015 Summer;15(2):154-61.
3
"First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.运用结局指标自对照设计主动监测新上市药物的安全性时存在“首波”偏倚。
Am J Epidemiol. 2014 Sep 15;180(6):636-44. doi: 10.1093/aje/kwu162. Epub 2014 Aug 1.
4
Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations.评估骨质疏松症药物治疗依从性对骨折风险影响的方法：系统评价与建议
Ther Adv Chronic Dis. 2010 Nov 1;1(4):149-162. doi: 10.1177/2040622310376137.
5
Continuing conservative care versus crossover to radiofrequency kyphoplasty: a comparative effectiveness study on the treatment of vertebral body fractures.继续保守治疗与交叉至射频椎体成形术：治疗椎体骨折的比较效果研究。
Eur Spine J. 2012 May;21(5):930-6. doi: 10.1007/s00586-012-2148-8. Epub 2012 Jan 11.